Evorel Conti patches are a type of continuous combined Hormone Replacement Therapy (HRT). They are a prescription-only treatment designed to manage the symptoms of menopause for women who have not had a hysterectomy, delivering a steady dose of two hormones through the skin.
Understanding Evorel Conti Patches for Menopause
Menopause is a natural biological process marking the end of menstrual cycles. The associated hormonal changes, particularly the decline in oestrogen, can lead to a range of symptoms that may impact daily life. For more detailed information, it is helpful to start by understanding menopause and perimenopause and the physiological changes involved.
Symptoms like hot flushes are a common response to fluctuating oestrogen levels affecting the body's temperature regulation. Evorel Conti patches work by replacing the hormones that the body is no longer producing at the same levels, thereby alleviating these symptoms.
The following table provides a concise overview of Evorel Conti.
Evorel Conti Patches at a Glance
| Feature | Description |
|---|---|
| Treatment Type | Continuous Combined Hormone Replacement Therapy (HRT) |
| Active Ingredients | Estradiol hemihydrate (an oestrogen) and Norethisterone acetate (a progestogen) |
| Method of Use | A transdermal patch applied to the skin, changed twice weekly. |
| Primary Use | To relieve menopausal symptoms such as hot flushes, night sweats, and vaginal dryness. |
| Indicated For | Postmenopausal women who have not had a hysterectomy (still have a uterus). |
This combination of hormones makes Evorel Conti an effective HRT option for many women.
The Two Active Ingredients
Evorel Conti is classified as a 'continuous combined' HRT because it consistently delivers two active ingredients:
- Estradiol: This is a form of oestrogen, the hormone that declines during menopause. Supplementing oestrogen levels addresses the underlying cause of many menopausal symptoms, helping to relieve hot flushes, reduce night sweats, and manage vaginal atrophy.
- Norethisterone Acetate: This is a synthetic form of progesterone, known as a progestogen. It is an essential component of HRT for any woman with a uterus. Oestrogen taken alone can lead to the thickening of the uterine lining (endometrial hyperplasia), which increases the risk of endometrial cancer. Norethisterone protects the endometrium by preventing this proliferation.
Because it contains both hormones, Evorel Conti provides a complete HRT regimen for women who have not had a hysterectomy.
With a significant number of women in the UK experiencing perimenopause or menopause, effective treatments are in high demand. Evorel Conti is an established, MHRA-approved option prescribed by healthcare professionals.
It is important to understand that Evorel Conti is a prescription-only treatment in the UK. It cannot be purchased over the counter and must be prescribed by a qualified healthcare professional following a thorough clinical assessment to determine its suitability and safety.
Patients can learn more about how UK-registered clinicians provide safe, regulated care through our women's health services and access the support they need.
How Evorel Conti Works to Relieve Menopausal Symptoms
An Evorel Conti patch functions as a hormone reservoir, working via transdermal delivery to release a steady dose of its active ingredients through the skin directly into the bloodstream. This method provides consistent hormone levels, helping to mitigate the fluctuations characteristic of menopause.
Inside each MHRA-approved patch are two active ingredients that work in tandem:
- Estradiol: A form of oestrogen.
- Norethisterone Acetate: A synthetic progestogen.
Each hormone has a specific role, which is why Evorel Conti is defined as a continuous combined HRT, indicated for women with a uterus.
Oestrogen Replacement
The primary cause of menopausal symptoms like hot flushes, night sweats, and mood changes is the significant decline in the body's oestrogen levels. The estradiol in the patch addresses this directly. As it is absorbed, it restores oestrogen levels, which helps to stabilise the body's thermoregulatory centre (the hypothalamus) and relieve vasomotor symptoms. Many women find their hot flushes and night sweats become less frequent and severe. Oestrogen replacement can also improve sleep quality, mood, and symptoms of vaginal dryness.
A key benefit of transdermal hormone delivery is that it bypasses the digestive system and initial metabolism by the liver. This is a notable difference from oral HRT tablets and is associated with a lower risk of venous thromboembolism (blood clots).
Protection of the Uterine Lining
While oestrogen replacement is necessary for symptom relief, unopposed oestrogen therapy can cause the lining of the uterus (the endometrium) to thicken. Over time, this endometrial hyperplasia increases the risk of endometrial cancer. The second hormone, norethisterone, serves a crucial protective function.
As a progestogen, norethisterone prevents the endometrium from thickening in response to oestrogen, thus reducing the associated cancer risk. This is why combined HRT, such as Evorel Conti, is the standard prescription-only treatment for women who have not undergone a hysterectomy.
The continuous delivery of both hormones from the patch ensures a balanced and steady dose. This system eliminates the need for daily pills and avoids sharp peaks and troughs in hormone levels, providing consistent symptom relief and endometrial protection. All treatment is overseen by a clinician from a regulated service, such as a UK-registered pharmacy.
How to Use Evorel Conti Patches Correctly
Using Evorel Conti patches correctly is straightforward and integral to the treatment's effectiveness. Following a consistent routine ensures a steady delivery of hormones.
As this is a prescription-only treatment, your clinician will provide personalised instructions. This guide provides general practical advice for using your patches.
Evorel Conti patches require changing twice a week. It is advisable to choose two specific days and adhere to this schedule (for example, Monday and Thursday, or Sunday and Wednesday). Setting a reminder can help maintain consistency.
Where and How to Apply the Patch
Correct application is essential for optimal hormone absorption and to minimise skin irritation.
- Choose a Location Below the Waist: The recommended application sites are the buttocks or lower abdomen. Avoid applying the patch on or near the breasts.
- Ensure Skin is Clean and Dry: Apply the patch to an area of skin that is clean, dry, and free from moisturisers, oils, or powders. These products can affect the adhesive and prevent the patch from sticking correctly. Do not apply to broken, sore, or irritated skin.
- Apply and Press Firmly: After opening the sachet and peeling off the protective liner, press the adhesive side firmly onto the chosen skin area. Hold it in place with the palm of your hand for approximately 30 seconds. The warmth helps to seal the patch to the skin.
It is very important to rotate the application site. Never apply a new patch to the same spot of skin you just used. As a general rule, wait at least one week before re-using a particular site. This practice significantly reduces the likelihood of skin irritation.
This infographic illustrates how the patch delivers consistent relief from menopausal symptoms.
This transdermal system allows for steady absorption of hormones, helping to smooth the hormonal fluctuations of menopause.
Daily Activities and Patch Adhesion
Evorel Conti patches are designed for normal daily life. They are waterproof, allowing for showering, bathing, and swimming without detaching.
If a patch does fall off, apply a new one to a different area of skin. It is important to maintain your original schedule. For example, if your change days are Monday and Thursday and a patch falls off on Tuesday, apply a new one immediately and still change it again as scheduled on Thursday. This ensures you continue to receive the correct dose of your prescribed medication.
Understanding the Benefits and Potential Side Effects
When considering any prescription-only treatment, it is essential to weigh the potential benefits against the possible risks. Evorel Conti patches can be highly effective for managing menopausal symptoms, but like all medications, they have potential side effects. This information is based on the official Patient Information Leaflet (PIL) and is intended to support, not replace, clinical consultation.
The primary benefit of Evorel Conti is relief from disruptive vasomotor symptoms. By providing a steady supply of oestrogen, the patches can significantly reduce the frequency and severity of hot flushes and night sweats, often leading to improved sleep and energy levels.
Beyond symptom control, Evorel Conti is also licensed for the prevention of osteoporosis in postmenopausal women at high risk of future fractures. Oestrogen decline accelerates bone density loss, and HRT can help to slow this process, providing long-term bone protection.
Common and Serious Side Effects
It is important to distinguish between common side effects, which often resolve with time, and rare but serious adverse events that require immediate medical attention.
The table below summarises potential side effects to help you monitor your health while using Evorel Conti. It does not replace a discussion with your healthcare provider.
Common and Serious Side Effects of Evorel Conti
| Side Effect Category | Examples | Recommended Action |
|---|---|---|
| Very Common | Application site reactions (redness, itching, rash). | Rotate the patch location with each application. Ensure skin is clean and dry before applying. Most reactions are mild and transient. |
| Common (up to 1 in 10 women) | Mood changes, headaches, breast tenderness, breakthrough bleeding or spotting (especially in the first 3-6 months). | These often improve as your body adjusts. Maintain a symptom diary and discuss any persistent or concerning side effects with your clinician. |
| Serious (Uncommon but require urgent attention) | Signs of a blood clot (e.g., painful swelling in one leg, sudden chest pain, shortness of breath), signs of a stroke (e.g., sudden unilateral weakness, slurred speech, vision changes). | Seek immediate medical help (call 999 or go to A&E). Stop using the patch and contact your clinician. |
| Serious (Rare but require urgent attention) | Signs of a severe allergic reaction (e.g., swelling of the face, lips, or throat; difficulty breathing), signs of liver problems (e.g., jaundice, dark urine). | Seek immediate medical help (call 999 or go to A&E). |
The body often needs time to acclimatise to the new hormone levels. Many common side effects tend to improve or resolve within the first few months of treatment.
The most frequently reported side effect is a local skin reaction at the application site. This may present as redness or itching, is usually mild, and can be minimised by systematically rotating the patch location.
Other common side effects, affecting up to 1 in 10 women, may include:
- Mood changes or low mood
- Headaches
- Breast tenderness or pain
- Irregular bleeding or spotting, which is particularly common during the initial months of use.
These early side effects often subside within the first three months as your body adjusts. However, you should always report any persistent or concerning symptoms to your prescribing clinician.
When to Seek Medical Advice
While serious adverse events are uncommon, it is vital to be aware of the warning signs. You must seek urgent medical assistance if you experience any symptoms of:
- A blood clot: This could manifest as painful swelling and warmth in your leg, sudden, sharp chest pain, or difficulty breathing.
- A stroke: Signs can include sudden numbness or weakness (especially on one side of the body), slurred speech, or sudden visual disturbances.
- A severe allergic reaction (anaphylaxis): This can involve swelling of the face, lips, or throat, leading to breathing difficulties.
Regular follow-up appointments with your clinician are an essential part of using this prescribed medication safely. These reviews ensure the treatment remains appropriate and provide an opportunity to address any concerns. All treatments supplied by a UK-registered pharmacy like XO Medical include this crucial clinical oversight for patient safety.
Navigating UK Supply Issues and Accessing Treatment
Hormone Replacement Therapy is an important treatment for managing menopausal symptoms. Consequently, supply shortages of HRT products can be a significant source of concern for patients. In the UK, high demand and manufacturing issues have occasionally led to shortages of popular treatments, including Evorel Conti patches.
These supply disruptions can cause uncertainty regarding treatment continuity. To manage such situations, UK health authorities may implement a Serious Shortage Protocol (SSP). An SSP is a measure that temporarily authorises community pharmacists to dispense a suitable alternative medication if the prescribed one is unavailable, without requiring a new prescription from the GP.
Evorel Conti patches have been subject to such shortages. High demand has at times outpaced supply from the manufacturer. In response, the government has used SSPs to allow pharmacists to substitute specific patches, ensuring patients can continue to access appropriate therapy and minimising treatment disruption.
Securing Treatment Through a Regulated Online Pharmacy
When local pharmacies face stock issues, a regulated online pharmacy can be a reliable alternative. These services often have robust supply chains and provide real-time stock information, which can eliminate the uncertainty of searching multiple local pharmacies for your prescribed medication.
Understanding how to get a prescription online is a practical step, particularly when faced with national supply challenges.
It is crucial to use a service that is regulated by the GPhC (General Pharmaceutical Council). This ensures the care provided meets the same professional standards as a high street pharmacy. The process begins with a secure online consultation, which is reviewed by a UK-registered clinician to confirm that the requested treatment, such as Evorel Conti patches, is clinically appropriate and safe for you.
A significant advantage of this model is care continuity. If a specific patch is unavailable, a clinician can review the patient's medical history and recommend a suitable, in-stock alternative, ensuring uninterrupted menopause management.
This clinician-led service is both safe and convenient. Once a prescription is approved, a UK-registered pharmacy dispenses the medication and delivers it directly to the patient in discreet packaging. For a detailed explanation of this modern approach to healthcare, please see our guide to using a regulated online pharmacy in the UK. The model prioritises continuous, safe, and effective care under the supervision of qualified healthcare professionals.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.
Is Evorel Conti a Safe and Appropriate Treatment for You?
Determining if Evorel Conti is a suitable and safe treatment is the most critical step. As an MHRA-approved, prescription-only treatment, it is not appropriate for everyone. A thorough clinical assessment is required to ensure the benefits of initiating HRT outweigh the potential risks, based on your personal and family medical history.
Providing a complete and accurate health history to your clinician is fundamental to patient safety. Certain pre-existing health conditions, known as contraindications, mean that using Evorel Conti could be harmful.
Who Should Not Use Evorel Conti Patches
A clinician will not prescribe Evorel Conti if you have, or have a history of, certain medical conditions. It is imperative to be fully transparent during your consultation.
Key contraindications for Evorel Conti include:
- A personal or family history of hormone-sensitive cancer, such as breast cancer, ovarian cancer, or endometrial cancer.
- A history of venous thromboembolism (blood clots in a vein), such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
- A known thrombophilic disorder (e.g., protein C, protein S, or antithrombin deficiency).
- Any undiagnosed vaginal bleeding.
- Severe liver disease, or a history of liver disease where liver function tests have not returned to normal.
- A recent myocardial infarction (heart attack) or stroke.
- A rare inherited blood condition called porphyria.
This list is not exhaustive. Your prescriber requires a comprehensive overview of your health and any other medications you are taking to make a safe assessment.
Patient safety is the primary concern. The regulated clinical process ensures that a UK-registered prescriber will only issue a prescription after they have personally determined that Evorel Conti is a safe and appropriate treatment for an individual's specific circumstances, in line with UK healthcare standards.
Ensuring Safe Access Through Clinical Assessment
In the UK, Evorel Conti patches can only be obtained following a comprehensive assessment by a qualified clinician. This process is designed to protect patient safety. When using a regulated online pharmacy, this involves completing a detailed and secure medical questionnaire. This confidential information is then carefully evaluated by a UK-registered clinician.
This system upholds the same high standards of care as a face-to-face appointment. Our guide on obtaining a UK online doctor prescription explains this regulated process in more detail. It ensures that any prescription from a service regulated by the GPhC adheres to the highest standards of patient safety.
Frequently Asked Questions About Evorel Conti
This section addresses common practical questions about using Evorel Conti to help you feel confident in your treatment.
Can I Cut Evorel Conti Patches in Half?
No, you must not cut an Evorel Conti patch.
Each patch is a sealed, matrix-type system designed to release a specific, controlled dose of hormones over several days. Cutting the patch damages this system, leading to an unpredictable and incorrect dose. This can render the HRT ineffective and potentially unsafe.
If you feel your dose is not suitable, do not modify the patch. Instead, you should consult your clinician. They can assess your symptoms and discuss alternative dosages or other types of HRT that may be more appropriate.
What Should I Do If I Experience Skin Irritation?
Minor redness or mild irritation at the application site is a common side effect that usually resolves on its own. The most effective way to prevent this is to rotate the application site with each new patch. It is recommended to allow at least one week before reusing the same area of skin.
Ensure your skin is completely clean and dry before applying a patch. Do not apply moisturisers, creams, or oils to the area, as this can affect the adhesive and may cause irritation. If the irritation is severe, persistent, or you develop blisters, remove the patch and contact your clinician for advice.
It is safe to obtain a prescription for Evorel Conti patches online, provided you use a UK-regulated service. Reputable online pharmacies are governed by regulatory bodies such as the General Pharmaceutical Council (GPhC) and engage only UK-registered clinicians for consultations.
The online assessment process is designed to be as rigorous as an in-person appointment. You will be required to complete a detailed medical questionnaire, which a qualified prescriber reviews to ensure the prescription-only treatment is safe and appropriate for you before any medication is dispatched from a UK-registered pharmacy.
How Long Does It Take for Evorel Conti to Start Working?
Most women begin to notice an improvement in their primary menopausal symptoms, such as hot flushes and night sweats, within the first few weeks of starting treatment.
However, it can take up to three months to experience the full, stabilising benefits of Evorel Conti patches. Consistency is crucial, so it is important to use the patches exactly as prescribed. A follow-up review is typically scheduled at around the three-month mark to assess your response to the treatment and make any necessary adjustments.
0 comments